ÂÜÀòÂÒÂ×

Kate is a co-founder of Radimmune, a pioneer in melanin-targeted radioimmunotherapy, and our Scientific Advisory Committee chairperson. She is currently The Fedoruk Centre for Nuclear Innovation Chair in Radiopharmacy at the University of Saskatchewan. She was formerly Professor and Olnick Faculty Scholar in Cancer Research at the Albert Einstein College of Medicine. Following her PhD in physical chemistry, she was a postdoctoral fellow in radiopharmaceutical chemistry at the Australian Nuclear Science and Technology Organization.